Davenport MS, Perazella MA, Yee J et al (2020) Use of Intravenous Iodinated contrast media in patients with kidney disease: Consensus statements from the American College of Radiology and the National Kidney Foundation. Radiology 294:660–668
Perelli F, Turrini I, Giorgi MG et al (2022) Contrast agents during pregnancy: pros and cons when really needed. Int J Environ Res Public Health 19:16699–16699
Article CAS PubMed PubMed Central Google Scholar
Kersey CB, Lele AV, Johnson MN et al (2023) The quality and safety of sedation and monitoring in adults undergoing nonoperative Transesophageal Echocardiography. Am J Cardiol 194:40–45
Article PubMed PubMed Central Google Scholar
Zierler BK (2004) Ultrasonography and diagnosis of venous thromboembolism. Circulation 109:9–14
Thackeray JT, Diekmann J (2022) Fibrin-targeted PET/CMR in Atrial Fibrillation. JACC Cardiovasc Imaging 15:516–518
Mendiola AS, Yan Z, Dixit K et al (2023) Defining blood-induced microglia functions in neurodegeneration through multiomic profiling. Nat Immunol 24:1173–1187
Article CAS PubMed PubMed Central Google Scholar
Wen T, Zhang Z (2023) Cellular mechanisms of fibrin (ogen): insight from neurodegenerative diseases. Front Neurosci 17:1–13
Kwaan HC, Lindholm PF (2019) Fibrin and fibrinolysis in Cancer. Semin Thromb Hemost 45:413–422
Article CAS PubMed Google Scholar
Whyte CS, Morrow GB, Mitchell JL, Chowdary P, Mutch NJ (2020) Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19. J Thromb Haemost 18:1548–1555
Article CAS PubMed PubMed Central Google Scholar
Shea BS, Probst CK, Brazee PL et al (2017) Uncoupling of the profibrotic and hemostatic effects of thrombin in lung fibrosis. JCI Insight 2
Proal AD, VanElzakker MB, Aleman S et al (2023) SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC). Nat Immunol 24:1616–1627
Article CAS PubMed Google Scholar
Kolodziej AF, Nair SA, Graham P et al (2012) Fibrin specific peptides derived by Phage Display: characterization of peptides and conjugates for imaging. Bioconjug Chem 23:548–556
Article CAS PubMed PubMed Central Google Scholar
Ciesienski KL, Yang Y, Ay I et al (2013) Fibrin-targeted PET probes for the detection of thrombi. Mol Pharm 10:1100–1110
Article CAS PubMed PubMed Central Google Scholar
Boros E, Rybak-Akimova E, Holland JP et al (2014) Pycup—A Bifunctional, cage-like Ligand for 64 Cu Radiolabeling. Mol Pharm 11:617–629
Article CAS PubMed Google Scholar
Ay I, Blasi F, Rietz TA et al (2014) In vivo molecular imaging of thrombosis and thrombolysis using a fibrin-binding positron emission tomographic probe. Circ Cardiovasc Imaging 7:697–705
Article PubMed PubMed Central Google Scholar
Oliveira BL, Blasi F, Rietz TA, Rotile NJ, Day H, Caravan P (2015) Multimodal Molecular Imaging reveals high Target Uptake and specificity of 111 In- and 68 Ga-Labeled fibrin-binding probes for Thrombus detection in rats. J Nucl Med 56:1587–1592
Article CAS PubMed Google Scholar
Blasi F, Oliveira BL, Rietz TA et al (2014) Effect of Chelate Type and Radioisotope on the imaging efficacy of 4 fibrin-specific PET probes. J Nucl Med 55:1157–1163
Article CAS PubMed Google Scholar
Blasi F, Oliveira BL, Rietz Ta et al (2015) Radiation dosimetry of the fibrin-binding probe 64Cu-FBP8 and its feasibility for positron emission tomography imaging of deep vein thrombosis and pulmonary embolism in rats. J Nucl Med 56:1088–1093
Article CAS PubMed Google Scholar
Blasi F, Oliveira BL, Rietz TA et al (2015) Multisite Thrombus imaging and fibrin content estimation with a single whole-body PET scan in rats. Arterioscler Thromb Vasc Biol 35:2114–2121
Article CAS PubMed PubMed Central Google Scholar
Izquierdo-Garcia D, Désogère P, Philip AL et al (2022) Detection and Characterization of Thrombosis in Humans Using Fibrin-Targeted Positron Emission Tomography and Magnetic Resonance. JACC Cardiovasc Imaging
Munchel JK, Misra AK, Collins SA et al (2024) Fibrin-PET Imaging Reveals Ongoing Lung Injury in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med
Shidahara M, Tashiro M, Okamura N et al (2013) Evaluation of the biodistribution and radiation dosimetry of the 18F-labelled amyloid imaging probe [18F]FACT in humans. EJNMMI Res 3:32–32
Article PubMed PubMed Central Google Scholar
Martinez-Moller A, Souvatzoglou M, Delso G et al (2009) Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data. J Nucl Med 50:520–526
Stabin MG, Siegel JA (2018) RADAR dose estimate report: a compendium of radiopharmaceutical dose estimates based on OLINDA/EXM version 2.0. J Nucl Med 59:154–160
Pfeifer A, Knigge U, Mortensen J et al (2012) Clinical PET of neuroendocrine tumors using 64Cu-DOTATATE: first-in-humans study. J Nucl Med 53:1207–1215
Article CAS PubMed Google Scholar
Laforest R, Dehdashti F, Lewis JS, Schwarz SW (2005) Dosimetry of 60/61/62/64Cu-ATSM: a hypoxia imaging agent for PET. Eur J Nucl Med Mol Imaging 32:764–770
Article CAS PubMed Google Scholar
Laforest R, Ghai A, Fraum TJ et al (2023) First-in-human evaluation of safety and dosimetry of 64 Cu-LLP2A for PET imaging. J Nucl Med 64(2):320–328
Sprague DR, Chin FT, Liow JS et al (2007) Human biodistribution and radiation dosimetry of the tachykinin NK1 antagonist radioligand [18F]SPA-RQ: comparison of thin-slice, bisected, and 2-dimensional planar image analysis. J Nucl Med 48:100–107
Hindorf C, Glatting G, Chiesa C, Lindén O, Flux G (2010) EANM dosimetry committee guidelines for bone marrow and whole-body dosimetry. Eur J Nucl Med Mol Imaging 37:1238–1250
Avila-Rodriguez MA, Rios C, Carrasco-Hernandez J et al (2017) Biodistribution and radiation dosimetry of [64Cu]copper dichloride: first-in-human study in healthy volunteers. EJNMMI Res 7:98–98
Article CAS PubMed PubMed Central Google Scholar
Persson M, El Ali HH, Binderup T et al (2014) Dosimetry of 64Cu-DOTA-AE105, a PET tracer for uPAR imaging. Nucl Med Biol 41:290–295
Article CAS PubMed Google Scholar
López-Rodríguez V, Galindo-Sarco C, García-Pérez FO, Ferro-Flores G, Arrieta O, Ávila-Rodríguez MA (2016) PET-based human dosimetry of the dimeric α v β 3 integrin ligand 68 Ga-DOTA-E-[c(RGDfK)] 2, a potential tracer for imaging tumor angiogenesis. J Nucl Med 57:404–409
Izquierdo-Garcia D, Désogère P, Fur ML et al (2023) Biodistribution, Dosimetry, and pharmacokinetics of 68 Ga-CBP8: A type I collagen–targeted PET probe. J Nucl Med 64:775–781
Article CAS PubMed PubMed Central Google Scholar
Quinn B, Dauer Z, Pandit-Taskar N, Schoder H, Dauer LT (2016) Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates. BMC Med Imaging 16:41–41
Comments (0)